Target intelligence / Profile preview

Ribosomal protein L3 pseudogene 4 (RPL3P4)

Target
RPL3P4
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L3 pseudogene 4 (RPL3P4) is a processed pseudogene in the human genome, named for its sequence similarity to the functional gene encoding ribosomal protein L3, a core component of the 60S ribosomal subunit. RPL3P4 does not code for a functional protein. It is one of multiple such processed pseudogenes dispersed throughout the genome, which arise as by-products of gene duplication and retrotransposition events and generally do not have known biological roles or direct disease associations[1][2]. RPL3P4 is not a protein-coding gene; it is a pseudogene, meaning it resembles a gene but is non-functional and does not produce a protein product[1][2]. The functional analog is Ribosomal protein L3 (*RPL3*), which is part of the ribosome, but RPL3P4 itself does not contribute to ribosome structure or function[1][2][5]. Pseudogenes are not considered druggable or therapeutic targets, nor are they established biomarkers. No drugs, mechanisms of action, disease associations, or safety considerations are listed for this pseudogene, as it lacks direct biological or therapeutic relevance in the same manner as protein-coding genes. There is nothing to suggest RPL3P4 is therapeutically actionable, has a physiologically relevant function, or plays any disease role. Instead, it is best considered a nonfunctional genomic artifact[1][2].

Other names
RPL3P4

Beyond the preview

Go deeper on Ribosomal protein L3 pseudogene 4 (RPL3P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L3 pseudogene 4 (RPL3P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call